Implementation of an Oral Chemotherapy Adherence Intervention
Recruiting
N/A
Interventional Study
Solid Tumor
Hematologic Malignancy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 21 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 160 (estimated)
- Sponsor
- UNC Lineberger Comprehensive Cancer Center · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to evaluate the effectiveness and usability of a newly developed oral anticancer agent adherence program implemented across 6 cancer clinics (two academic, two urban, and two rural). The study will include 160 adult participants with either solid tumors or hematologic malignancies who have been taking oral anticancer agents for at least six months.
This study will have t…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult (age ≥21 years-old) patients
* Diagnosed with a solid or hematologic malignancy
* Monotherapy on oral anticancer agent on treatment for at least 6 months
Exclusion criteria:
* Patients on time-limited or intermittent therapy (non-continuous)
* Patients on comfort (end-…
Contacts